Literature DB >> 5261092

Profound leukopenia following asparaginase treatment in a patient with acute lymphoblastic leukaemia.

M J Oehlers, W Fetawadjieff, H J Woodliff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5261092     DOI： 10.5694/j.1326-5377.1969.tb107492.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  3 in total

1.  Asparaginase-associated myelosuppression and effects on dosing of other chemotherapeutic agents in childhood acute lymphoblastic leukemia.

Authors:  Reid Merryman; Kristen E Stevenson; William J Gostic; Donna Neuberg; Jane O'Brien; Stephen E Sallan; Lewis B Silverman
Journal:  Pediatr Blood Cancer       Date:  2012-04-24       Impact factor: 3.167

2.  Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow-Berlin 2002.

Authors:  Alexander Karachunskiy; Gesche Tallen; Julia Roumiantseva; Svetlana Lagoiko; Almira Chervova; Arend von Stackelberg; Olga Aleinikova; Oleg Bydanov; Lyudmila Bajdun; Tatiana Nasedkina; Natalia Korepanova; Sergei Kuznetsov; Galina Novichkova; Marina Goroshkova; Dmitry Litvinov; Natalia Myakova; Natalia Ponomareva; Evgeniya Inyushkina; Konstantin Kondratchik; Julia Abugova; Larisa Fechina; Oleg Arakaev; Alexander Karelin; Vladimir Lebedev; Natalia Judina; Gusel Scharapova; Irina Spichak; Anastasia Shamardina; Olga Ryskal; Alexander Shapochnik; Alexander Rumjanzew; Joachim Boos; Günter Henze
Journal:  J Cancer Res Clin Oncol       Date:  2019-03-06       Impact factor: 4.553

Review 3.  Asparaginase-associated toxicity in children with acute lymphoblastic leukemia.

Authors:  Nobuko Hijiya; Inge M van der Sluis
Journal:  Leuk Lymphoma       Date:  2015-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.